Continuing evolution in breast cancer surgical management

Journal of Clinical Oncology

Volumn 23, Issue 8, 2005, Pages 1603-1606

  Mamounas, Eleftherios P ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; TAMOXIFEN;

ADJUVANT THERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; EDITORIAL; GENETIC SUSCEPTIBILITY; HUMAN; MASTECTOMY; METASTASIS; MICROMETASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; MULTIMODALITY CANCER THERAPY; NOTE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, RADICAL; RANDOMIZED CONTROLLED TRIALS;

EID: 15544365698     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.01.015     Document Type: Editorial

References (37)

1. Fisher B: Laboratory and clinical research in breast cancer-A personal adventure: The David A. Karnofsky memorial lecture. Cancer Res 40:3863-3874, 1980
2. Halsted W: The results of radical operations for the cure of carcinoma of the breast. Ann Surg 46:1-19, 1907
3. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
4. Fisher B, Redmond C, Poisson R, et al: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822-828, 1989
5. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002
6. Veronesi U, Saccozzi R, Del Vecchio M, et al: Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 305:6-11, 1981
7. NIH consensus conference. Treatment of early-stage breast cancer. JAMA 265:391-395, 1991
8. Early Breast Cancer Trialists' Collaborative Group: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists' Collaborative Group. N Engl J Med 319:1681-1692, 1988
9. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: An overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 351:1451-1467, 1998
10. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer: An overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 352:930-942, 1998
11. Newman LA, Kuerer HM: Advances in breast conservation therapy. J Clin Oncol 23:1685-1697, 2005
12. Kuerer HM, Newman LA: Lymphatic mapping and sentinel lymph node biopsy for breast cancer: Developments and resolving controversies. J Clin Oncol 23:1698-1705, 2005
13. Esserman L, Kaplan E, Partridge S, et al: MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 8:549-559, 2001
14. Martincich L, Montemurro F, Cirillo S, et al: Role of magnetic resonance imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy. Radiol Med (Torino) 106:51-58, 2003
15. Krag DN, Weaver DL, Alex JC, et al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-340, 1993
16. Goldhirsch A, Wood WC, Gelber RD, et al: Meeting highlights: Updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21:3357-3365, 2003
17. Veronesi U, Paganelli G, Viale G, et al: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546-553, 2003
18. Kern KA: Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. J Am Coll Surg 195:467-475, 2002
19. Shimazu K, Tamaki Y, Taguchi T, et al: Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer. Ann Surg 237:390-398, 2003
20. van der Ent FW, Kengen RA, van der Pol HA, et al: Halsted revisited: Internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 234:79-84, 2001
21. Tanis PJ, Nieweg OE, Valdes Olmos RA, et al: Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients. Br J Cancer 87:705-710, 2002
22. Jansen L, Doting MH, Rutgers EJ, et al: Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg 87:920-925, 2000
23. Estourgie SH, Tanis PJ, Nieweg OE, et al: Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol 10:935-941, 2003
24. Dupont EL, Salud CJ, Peltz ES, et al: Clinical relevance of internal mammary node mapping as a guide to radiation therapy. Am J Surg 182:321-324, 2001
25. Freedman GM, Fowble BL, Nicolaou N, et al: Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys 46:805-814, 2000
26. Wong SL, Edwards MJ, Chao C, et al: Sentinel lymph node biopsy for breast cancer: Impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 192:684-691, 2001
27. Cody HS 3rd, Hill AD, Tran KN, et al: Credentialing for breast lymphatic mapping: How many cases are enough? Ann Surg 229:723-728, 1999
28. Motomura K, Inaji H, Komoike Y, et al: Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol 76:95-99, 2001
29. Mirzaei S, Rodrigues M, Hoffmann B, et al: Sentinel lymph node detection with large human serum albumin colloid particles in breast cancer. Eur J Nucl Med Mol Imaging 30:874-878, 2003
30. Haigh PI, Hansen NM, Giuliano AE, et al: Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. J Nucl Med 41:1682-1688, 2000
31. Giuliano AE, Haigh PI, Brennan MB, et al: Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18:2553-2559, 2000
32. Clarke D, Mansel RE, on behalf of ALMANAC trialists group: The learning curve in sentinel node biopsy (SNB) in breast cancer: Results from the ALMANAC trial. Breast Cancer Res Treat 69:212, 2001 (abstr 15)
33. Mansel RE, Goyal A, Necombe RG, et al: Objective assessment of lymphedema, shoulder function and sensory deficit after sentinel node biopsy for invasive breast cancer: ALMANAC trial. Breast Cancer Res Treat 88:S12, 2004 (abstr 15)
34. Ross MI: Sentinel node dissection in early-stage breast cancer: Ongoing prospective randomized trials in the USA. Ann Surg Oncol 8:77S-81S, 2001
35. Hurkmans CW, Borger JH, Rutgers EJ, et al: Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: The dummy run. Radiother Oncol 68:233-240, 2003
36. Bear HD, Anderson S, Brown A, et al: The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 21:4165-4174, 2003
37. Gianni L, Baslega J, Eiermann W, et al: First report of the European Cooperative Trial in operable breast cancer (ECTO): Effect of primary systemic therapy. Proc Am Soc Clin Oncol 21:34a, 2002 (abstr 132)